PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
May 3, 2026

Burden of Influenza and Cost-Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India.

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAnand KrishnanAPAslesh Ottapura PrabhakaranKSKusum Shekhawat

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates cost-effectiveness of influenza vaccination in older adults, highlighting implications for public health.

Key Points

  • This research aims to assess the cost-effectiveness and budgetary impact of seasonal influenza vaccination for adults aged 60 and above in India.
  • Estimated disease burden and health care utilization from community cohorts and hospital studies at four sites.
  • Used a decision analysis model to evaluate inactivated trivalent influenza vaccination for older adults.
  • Conducted deterministic and probabilistic sensitivity analyses and calculated ICER for different vaccination strategies.
  • Older adults faced 5.3 million influenza acute respiratory infections (ARIs) in 2021, resulting in 36,149 hospitalizations and 84,613 deaths.
  • The ICER for facility-based vaccination was US$1979 and for outreach-based vaccination was US$1851, both below the cost-effectiveness threshold.
  • Vaccinating older adults with comorbidities was the most cost-effective approach with minimal budgetary impact.

Cite This Study

Krishnan et al. (2026) studied this question.

synapsesocial.com/papers/69f6e62e8071d4f1bdfc6c52https://doi.org/10.1111/irv.70264
View Full Paper
Ask AI
Bookmark
Share